Table 1: Characteristics of flare patients
whose SF was identified as PRG4-deficient and were selected for lubrication testing,
and normal (NL) SF from cadaveric donors. * = significantly higher (p <
0.001) compared to normal.
Sample |
Age |
Sex |
Days post injection |
Aspirate Volume (mL) |
Total Protein (mg/mL) |
Flare 1 L |
47 |
M |
11 |
27 |
37.2 |
Flare 1 R |
47 |
M |
11 |
32 |
35.3 |
Flare 2 |
53 |
M |
4 |
55 |
32.0 |
Flare 3 |
48 |
F |
7 |
60 |
46.8 |
Flare 4 |
47 |
F |
1 |
22 |
25.5 |
Flare Avg |
48 (46, 51) |
|
|
39.2 (24.2, 54.2)* |
35.4 (28.5, 42.2)* |
NL Avg
(N = 29) |
55 (51, 59) |
6F, 12M |
|
3.6 (2.2, 4.9) |
15.4 (13.0, 17.8) |
Data
are presented as mean with 95% confidence interval (lower limit, upper limit).
L = left, R = right, M = male, F = female, Avg =
average, NL = normal. * = significantly higher than NL, p < 0.05.